Abstract Very low density lipoproteins, newly secreted by cultured rat hepatocytes into a serum-free medium, contain some cholesteryl esters although the percentage of total cholesterol in ester form is less than that in plasma very low density lipoproteins. When acyl CoA:cholesterol acyltransferase activity in hepatocytes was stimulated by the addition of 25-hydroxycholestero1 (10 pg/ml) or mevalonolactone (1 mM), the absolute amount of esterified cholesterol secreted in very low density lipoproteins increased significantly, but the amount of free cholesterol decreased or showed no change. Thus the percentage of very low density lipoprotein cholesterol in ester form increased, in some experiments to as much as 50% of the total. These results provide additional evidence that hepatic acyl CoA:cholesterol acyltransferase plays a role in the generation of some of the cholesteryl ester in newlysecreted lipoproteins. They further suggest that changes in the activity of the enzyme can potentially regulate the fraction of cholesterol secreted in esterified form.-Drevon, C. A., S. C. Engelhorn, and D. Steinberg. Secretion of very low density lipoproteins enriched in cholesteryl esters by cultured rat hepatocytes during stimulation of intracellular cholesterol esterification. J . Lipid Res. 1980 Much of the cholesteryl ester moiety in plasma lipoprotein fractions is probably formed within the plasma through the action of 1ecithin:cholesterol acyltransferase (LCAT) (1). In patients with an inherited LCAT deficiency, only 5-17% of total plasma cholesterol is present as cholesteryl ester (1) compared to about 75% in normal subjects. Almost all the cholesteryl ester in the plasma of these patients can be recovered in the very low density lipoprotein (VLDL) fraction (2). Since there is no measurable LCAT activity in the plasma of these patients, there must be alternative sources of this plasma VLDL cholesteryl ester, including secretion by liver andlor intestine of VLDL (or VLDL precursors) already containing cholesteryl esters. It has been previously demonstrated that VLDL isolated from the Golgi apparatus in rat liver contains some cholesteryl ester (3), and that nascent lipoproteins secreted by perfused rat liver (4-7) and cultured rat hepatocytes (8) also contain a significant amount of cholesteryl ester.
. 1ecithin:cholesterol acyltransferase . 25-hydroxycholesterol . mevalonolactone Much of the cholesteryl ester moiety in plasma lipoprotein fractions is probably formed within the plasma through the action of 1ecithin:cholesterol acyltransferase (LCAT) (1). In patients with an inherited LCAT deficiency, only 5-17% of total plasma cholesterol is present as cholesteryl ester (1) compared to about 75% in normal subjects. Almost all the cholesteryl ester in the plasma of these patients can be recovered in the very low density lipoprotein (VLDL) fraction (2). Since there is no measurable LCAT activity in the plasma of these patients, there must be alternative sources of this plasma VLDL cholesteryl ester, including secretion by liver andlor intestine of VLDL (or VLDL precursors) already containing cholesteryl esters. It has been previously demonstrated that VLDL isolated from the Golgi apparatus in rat liver contains some cholesteryl ester (3), and that nascent lipoproteins secreted by perfused rat liver (4-7) and cultured rat hepatocytes (8) also contain a significant amount of cholesteryl ester.
When guinea pigs (9) (10) (11) or rats (12) are given dietary supplements of cholesterol, there is an increase in acy1CoA:cholesterol acyltransferase (ACAT) activity in microsomes of intestinal mucosal cells and an increase in the amount of cholesteryl ester in the triglyceride-rich lipoproteins of' intestinal lymph. Since LCAT activity in intestinal lymph is very low (10, 13), these data suggest that intracellular ACAT may play a role in the production of cholesteryl esters for incorporation into intestinal VLDL prior to its secretion. ACAT activity in cultured rat hepatocytes can be increased by incubation with 25-hydroxycholesterol or with high concentrations of mevalonolactone (14) . We present data in this report showing that the rate of secretion of newly-synthesized ester cholesterol into VLDL is increased when ACAT activity is increased in cultured hepatocytes and that the net cholesteryl ester content of nascent VLDL is also increased. \\-ere obtained from Grand Island Biological Co., Berkeley, <:A.
MATERIALS AND METHODS

Chemicals
Perfusion and incubation media
Rat livers Ivere perfused with ;t modified calciumfree Hanks solution (16) as described earlier (8) . An ar-ginine-free Dulbecco's modified Eagle's medium (DME) (8), supplemented Ivith glucose (40 m M ) . ornithine (0.4 m M ) , and 10 mM HEPES buffer from Grand Island Biological Co., Santa Clara, <:.4 \vas used as the standard incubation medium.
Isolation and cell culture of hepatocytes
T h e isolation of rat heptocytes w a s based upon the method described by Berry and Friend ( 1 7 ) . except that sterile conditions were maintained throughout. T h e detailed procedures for cell culture and f i x isolation of medium VLDL havc been described previously (8). T h e cells were plated in 60-o r I00-mnt Contui-dishes at 3 x I O 6 and Li x 10fl cells per dish. respectivel),. The ;tn~oiiiit o f inediiini (arginine-free DME medium containing FCS ( Y O % ) , insulin ( 1 0 pg/ml), penicillin G (100 units/ml), and sti-eptomyci~i tor I 00-nim dishes, and the cells w t~c maintained a t 39°C in a 95% air-5g C 0 2 atmosphere. T h e medium was centrifuged at d 1.006 g/ml to isolate VLDI, secreted by the liver cells (8, 19) . T h e top fraction \vas then extracted with ch1orofi)rmmethanol as described above, and the major lipid cl, c~sses . . covery of previousl!. pi-eparetl rat plasma VLDL, tjy centrifugation rrac about 90% and the recovery of labeled cholesterol and triglycerides through the ivere quantified as described lielo\v. The re-FTI,(: system Tvas also 90%.
Chemical analysis
Protein was measured according to Lo\rry et al. (20) . Free cholesterol and ester cholesterol were determined by gas-liquid chromatography using psitostetol as an internal standard. A Varian Aerogi-aph. series 2 100, equipped with a 6 ft, 2 mni I.D.
column, packed with 3% SP 2250 on 8011 00 mesh Supelcoport (Supelco) was used at 295°C ivith argon ( 3 0 n i l/m i 11 ) as ca r 1. ie r gas. S te 1-01s , triglycerides , a ti d phospholipids were also measured using a charring method as desci-ibed b y Marsh and Lt'einstein (2 I ).
RESULTS
I t has been shown previously that when rat hepatocytes are incubated with [3H]glycerol, niore than 95% of the labeled triglycerides secreted arc recovered in the d < 1.006 giml fraction and that 3H-labeled triglyceride secretion is linear as a filnction of time for 3-3 h r (8). Thus the rate of V I B L secretion can be closely approximated from the total "H-labeled triglyceride appearing in the medium over 5 hr. As shown in Table 1 , addition of 25hydroxy-cholesterol to the medium had little o r no effect on
In the experiment summarized in The hepatocytes were plated iri DME triediuni containing 20% FCS. .4fter 5 h r inrubation the medium was changed to serum-free DME medium with o r without 25-hydroxycholesterol (10 pgiml) and incubation was continued for 1 hr. T h e VLDL secreted during this first hour would probably show less than the maximal effect of. the 25-hydroxycholesterol since a significant amount of prefot-nied VLDI, is secreted during the initial hour. Therefore, the medium harvested at 1 hi-was discarded. After another 5 hr incubation at 39"C, the medium was harvested and centrifuged at d 1.006 g/ml at 4°C for 18 hr to isolate VLDL. The mass of free and total c-holestrrol was determined by gas-liquid chromatography using p-sitosterol as an internal standat-cl. The data represent means ? S.D. of I2 drterniinations.
percentage of total cholesterol present in ester form increased from 26.7% to 48.7%.
High concentrations of mevalonolactone in the medium also increase hepatocyte ACAT activity (14) . Measurements of net free and ester cholesterol secretion in VLDL were made in the presence and in the absence of 1 mM mevalonolactone ( Table 4) . Incubation was extended to 20 hr to increase the yield of VLDL for mass measurements. In each of three experiments, incubation with mevalonolactone increased the net amount of VLDL ester cholesterol secreted. There was a concomitant decrease in free cholesterol content, resulting in a marked increase in the percentage of total cholesterol in ester form.
However, there was no consistent change in total VLDL cholesterol.
I t was necessary to consider the possibility that some of the cholesteryl ester in newly-secreted VLDL might be attributable to the action of lecithin: cholesterol acyltransferase (LCAT). Hepatocytes were incubated for 20 hr in serum-free DME medium and the medium from 32 plates was combined.
This was divided into two equal aliquots. From one aliquot, the VLDL fraction was isolated and analyzed for cholesteryl ester content. T h e second aliquot of harvested medium was distributed into 16 empty culture dishes and incubated for an additional 20 h r in the absence of cells and then VLDL was isolated for Hepatocytes were plated in DME containing 20% FCS as described in the Method section. After 5 hr incubation the medium was changed to serum-free DME with or without mevalonolactone (1 mM) and incubated for 20 hr at 39°C. T h e medium was harvested and centrifuged d 1.006 g/ml at 4°C for 18 hr to isolate VLDL. T h e mass of free and total cholesterol was determined by gas-liquid chromatography using p-sitosterol as an internal standard. T h e data represent means S.D. of 3-6 determinations.
analysis. The amount of VLDL ester cholesterol secreted during the first 20-hr incubation was 1.80 -r-0.12 pg/mg of cell protein. The ester cholesterol in the VLDL isolated from the medium incubated an additional 20 hr without cells corresponded to 2.04 5 0.44 pg/mg cell protein. Thus, the increment in VLDL ester cholesterol over the second 20-hr interval was 0.24 pglmg cell protein, an increase of only 13%. Thus, it appears that the rate of ester cholesterol formation by action of LCAT on secreted lipoproteins can account for only a small fraction at most of the total ester cholesterol isolated.
As a further test of the possible significance of secreted LCAT, hepatocytes were incubated for 24 hr in seruni-free DME medium alone or in medium containing 25-hydroxycholestero1 (10 pg/ml) or DLmevalonolactone ( 1 mM). At the end of the incubation, the activity of LCAT in the medium was assayed by the method of Glomset and Wright (22) . The LCAT activity recovered in the medium was less in the presence of 25-hydroxycholesterol or mevalonolactone than in the control dishes, showing that the increase in VLDL ester cholesterol induced by these substances cannot be attributed to a greater rate of secretion of LCAT in their presence.
DISCUSSION
The data presented in this report demonstrate that incubation of rat hepatocytes in the presence of 25-hydroxycholesterol or mevalonolactone increases the fraction of newly-secreted VLDL cholesterol present in ester form. Both 25-hydroxycholesterol and mevalonolactone have previously been shown to increase ACAT activity by rat hepatocytes (14, 23) . Thus, the simplest interpretation of the results is that changes in ACAT activity can potentially regulate the cholesteryl ester content of newly-secreted VLDL. It has been shown previously that cholesterol feeding increases ACAT activity in the liver (24, 25) and that the cholesteryl ester content of VLDL secreted by perfused livers from cholesterol-fed rats can be markedly increased (7) . It has been proposed on the basis of kinetic evidence that esterification of cholesterol within the liver may be responsible for most of the cholesteryl esters found in the plasma of cholesterol-fed rabbits (26) . In livers of cholesterolfed animals, the lipid content, and particularly the cholesteryl ester content, is enormously increased and these stores of preformed esters might be responsible for the higher ester cholesterol content of secreted lipoprotein. The results of the present studies, particularly those experiments lasting only 5 hr, suggest that an increase in the activity of ACAT, without much change in net liver cholesteryl ester content, is sufficient to influence the cholesteryl ester content of nascent VLDL.
In the present studies hepatocytes were incubated in the absence of any added serum or serum lipoproteins. This does not in itself necessarily rule out the possibility that some of the ester cholesterol found in VLDL might have arisen from the action of 1ecithin:cholesterol acyltransferase (LCAT) activity secreted from the hepatocytes into the medium and acting on lipoproteins also secreted by the hepatocytes into the medium. Several considerations made it a priori unlikely that this could account for much of the VLDL cholesteryl ester. Marsh (5) used single-pass perfusion through the rat liver and chilled the perfusate immediately to prevent LCAT activity. The ester cholesterol in the nascent VLDL accounted for 23% of the total. In view of the range of values reported, the percentage may have been as high as 44% in some perfusions. Hamilton et al. (6) analyzed VLDL secreted by rat livers perfused with a serum-free medium and found that the fraction of ester cholesterol in VLDL was not altered by the addition of an inhibitor of LCAT. They found that approximately 30% of the cholesterol was present as ester with or without the addition of 5,5'-dithionitrobenzoic acid. In the present studies, the percentage of cholesterol present in ester form was 26.7 in 5-hr incubations and ranged from 18-42 in 20-hr incubations. Davis et al. (8) determined the ester cholesterol content of VLDL accumulating during the first 24 hr of hepatocyte culture and found the value to be 13%; when the VLDL was allowed to accumulate over 3 days of incubation, which should have allowed maximal opportunity for LCAT activity to convert free cholesterol to ester. only 23%-of the cholesterol was present in ester form. The possible contribution of secreted LCAT was tested directly and, as reported above, it was shown that cholesterol esterifying activity in the medium would account for less than 15% of the total ester cholesterol recovered and that neither 25-hydroxycholestero1 nor mevalonolactone increased the amount of LCAT in the medium. Thus the stimulation of ester cholesterol secretion in VLDL observed cannot be attributed to esterification of free cholesterol after secretion into the medium.
The percentage of total cholesterol present in ester form in nascent VLDL was not as high as that found in rat plasma VLDL. Presumably a significant fraction of the cholesteryl ester present at steady state in vivo derives from activity of LCAT in the plasma compartment (1). In man it is generally accepted that most of the plasma cholesteryl esters are formed by the action of LCAT. Indeed, it has been reported that human liver contains no measurable A C A T activity (27) . However, it has been recently demonstrated by Balasubramaniam et al. (28) , and by studies in this laboratory,2 that there is significant ACAT activity in human liver. Moreover, the presence of a significant amount of cholesteryl ester in the plasma VLDL of patients with total LCAT deficiency implies that either hepatic o r intestinal A C A T must be involved in formation of at least some of the cholesteryl esters in plasma.
T h e sequence of events by which free cholesterol and ester cholesterol become incorporated into nascent VLDL is not known. In the present studies it appeared that stimulation of ACAT increased the percentage of VLDL cholesterol in ester form but did not change the total cholesterol content significantly ( Table 4) . In other words, it appeared that a certain amount of cholesterol was targeted for incorporation into VLDL and that stimulation of ACAT simply resulted in conversion of some of that cholesterol from the free to the esterified form. T h e VLDL secreted by livers of cholesterol-fed rats shows a marked increase in ester cholesterol content arid a concomitant decrease in VLDL triglyceride content (7) , implying a replacement of triglycerides by cholesteryl esters in the apolar lipid core o f the lipoproteins. However, in the present studies, 25-hydroxycholesterol increased the ester cholesterol in VLDL without significantly affecting VLDL triglyceride content. It will be of interest to study the size and structure of these ester cholestex-ol-rich VLDL. m T h e investigation was supported by National Institutes of Health Research Grant HL 34197, awarded by the National Heart, Lung, and Blood Institute, PHS/DHHS. 12 Map 1980, and in rr-rrui~ed /orm 7 July 1980. 
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